New algorithm identifies patients harboring tumor-causing defect found in multiple cancers
Medications known as PARP inhibitors have emerged as a promising therapy for several forms of cancer fueled by a defect
Read more
Medications known as PARP inhibitors have emerged as a promising therapy for several forms of cancer fueled by a defect
Read more